Event Information

Share this event

Date and Time



Francis Crick Institute

1 Midland Road



United Kingdom

View Map

Event description


RET Research Collaborative Network inaugural meeting. Exchange ideas and collaborate to facilitate innovation in research and clinical care. RET gene mutations are responsible for a range of rare diseases including multiple endocrine neoplasia II, famillial and sporadic medullary thyroid cancer and phaeochromocytomas, Hirschsprung's disease, congenital kidney and urinary tract abnormalities and intellectual disabilities. A free event for health professionals and researchers supported by the Francis Crick Institute and the Society for Endocrinology.


08:00-09:00 Registration and refreshments

09:00-09:10 Welcome (Tom Kurzawinski and Rakhee Chauhan)

​Session 1: An Introduction to RET and MEN2 (Chairs: Professor Rajesh Thakker, Mrs Jo Grey)

09:10-09:35 A RETrospective view of GDNF signalling (Professor Neil McDonald, Senior Group Leader, Francis Crick Institute)

09:35-10:00 Testing for RET: indications, results, VUS (Dr Louise Izatt, Consultant in Clinical Genetics, Guy's and St Thomas's NHS Foundation Trust and King's College London)

10:00-10:25 Thyroid Surgery in MEN2: A Gospel according to RET? (Mr Tom Kurzawinski, Consultant Endocrine Surgeon, UCLH and GOSH)

10:25-10:50 RET and Oncogenesis with a focus on MEN2 Syndrome (Dr Rakhee Chauhan, Postdoctoral Research Fellow, Francis Crick Institute)

10:50-10:55 Session Discussion

10:55-11:15 Networking Refreshment Break

Session 2: RET and Hirschsprung’s Disease (Chairs: Dr Nikhil Thapar, tbc)

11:15-11:40 Sex differences in the roles of RET iso forms in the enteric nervous system and brain (Robin Lovel-Badge / Rosalyn Flowers, Senior Group Leader / PhD Student, Francis Crick Institute)

11:40-12:05 Identification, treatment and genetics of Hirschsprung's Disease (Dr Robert M W Hofstra, Head of Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands)

12:05-12:30 Structural insights into RET folding (Dr Svend Kjaer, STP Deputy, Francis Crick Institute)

12:30-12:40 Session Discussion

12:40-13:30 Lunchtime Networking

Session 3: Diverse Roles of RET (Chairs: Professor Marta Korbonits, Dr Caroline Brain)

13:30-13:55 The Pituitary and RET (Professor Clara Alvarez, Santiago de Compostela, Spain)

13:55-14:20 Parkin regulates RET protein levels (Dr Edgar Kramer, Group Leader, University of Plymouth)

14:20-14:45 Novel functions in RET signalling: RET and GFRAL in body weight regulation (Dr Sebastian Jorgensen, Novo Nordisk)

14:45-15:10 Activation of RET signalling improves haematopoietic stem cell potency and bone marrow transplantation (Dr William Grey, Postdoctoral Research Fellow, Francis Crick Institute)

15:10-15:35 Session Discussion

15:35-15:55 Networking Refreshment Break

Session 4: Targeting RET in Oncology (Chairs: Dr Rakhee Chauhan, Professor Ashley Grossman)

15:55-16:20 TracerX RET fusions in NSCLC (Dr Crispin Hiley, Senior Lecturer & Consultant Clinical Oncologist, UCLH)

16:20-16:45 Therapy of human cancers with RET fusion: from multiple kinase inhibitors to specific inhibitors (Dr Takashi Kohno, Chief of the Devision of Genome Biology, National Cancer Centre Research Institute, Japan)

16:45-17:10 Targeting RET clinically: past and present therapeutics (Dr Kate Newbold, Consultant Clinical Oncologist, The Royal Marsden Hospital, London)

17:10-17:35 Next generation RET inhibitors: the future is here! Blueprint BLU-667 clinical efficacy in lung cancer and medullary thyroid cancer (Dr Martin Forster, Associate Professor and Consultant in Medical Oncology, UCL Cancer Institute / UCLH)

17:35-17:45 Session Discussion

17:45-17:50 Closing Remarks

The event will be followed by a networking drinks reception at the Norfolk Arms

CPD Accreditation with the Royal College of Physicians applied for

[The programme may be subject to change without notice]

Share with friends

Date and Time


Francis Crick Institute

1 Midland Road



United Kingdom

View Map

Save This Event

Event Saved